Related by context. Frequent words. (Click for all words.) 77 safety tolerability pharmacokinetics 71 pharmacodynamics 71 safety tolerability 69 pharmacokinetics 68 pharmacokinetic profile 67 pharmacodynamic 67 tolerated dose MTD 67 PXD# 66 dose escalation trial 66 Pharmacokinetic 66 Phase 1b trial 66 pharmacokinetic 65 tolerability 65 dose escalation study 65 antiviral activity 64 orally bioavailable 64 immunogenicity 64 antitumor activity 63 axitinib 63 Phase Ia 62 randomized Phase III 62 single ascending dose 62 Phase 2a trial 62 dose limiting toxicities 62 tolerability profile 62 PS# [001] 62 CYT# 62 imetelstat 62 pharmacokinetic properties 62 Phase 1b clinical 61 investigational oral 61 active comparator 61 dose regimens 61 Phase IIa clinical 61 dosing regimens 61 dose cohorts 61 label dose escalation 61 Phase Ib 61 vivo efficacy 61 Phase 1a 61 phase 2a 61 efficacy 61 CA4P 60 phase IIa 60 radiolabeled 60 Phase 1b 60 Phase 2b study 60 Phase IIa trial 60 ISIS # 60 blind randomized placebo 60 HGS ETR1 60 intravenously administered 59 multiple ascending dose 59 CYC# 59 Alpharadin 59 RG# [001] 59 BAY #-# 59 pharmacokinetic studies 59 Phase III randomized 59 Phase 2a clinical 59 xenograft models 58 blinded placebo controlled 58 rHuPH# 58 antitumor 58 seliciclib 58 immunomodulator 58 vicriviroc 58 GRN#L 58 PEG Interferon lambda 58 placebo controlled 58 eculizumab 58 IMGN# 58 genotoxic 58 Tolerability 58 multicenter randomized double 58 randomized controlled clinical 58 randomized placebo controlled 58 NGX# 57 phase IIb 57 PF # [001] 57 potent inhibitor 57 eltrombopag 57 blind placebo controlled 57 AP# [003] 57 noninferiority 57 IDX# 57 INCB# [002] 57 DB# [003] 57 plus prednisone 57 tezampanel 57 CTCE 57 teduglutide 57 kinase inhibitor 57 Preclinical studies 57 Phase 2b trial 57 serum concentrations 57 TELCYTA 57 GSK # 57 double blind placebo 57 Azixa 57 OXi#